Prospettive Sociali e Sanitarie

Caleb M. Adler, John Adams, Melissa P. DelBello, Scott K. Holland, Vince Schmithorst, Ari Levine, Kelly Jarvis, and
Stephen M. Strakowski
Evidence of White Matter Pathology in Bipolar Disorder Adolescents Experiencing Their First Episode of Mania: A
Diffusion Tensor Imaging Study 322-324
Communications and Updates
Letters to the Editor:
INGEBORG WILTING, O.M. SMALS, N.J. HOLWERDA, R.H. MEYBOOM, M.L. De BRUIN, and T.C.G.
EGBERTS QTc Prolongation and Torsades de Pointes in an Elderly Woman Taking Fluoxetine 325
MONIQUE YOHANAN, JASDEEP S. AULAKH, JOANNE WEITH, and JAMES W. HAWKINS Pisa Syndrome in a
Patient in a Wheelchair Taking Valproic Acid 325-326
NATHALIE GODART, SYLVIE BERTHOZ, FABIENNE PERDEREAU, and PHILIPPE JEAMMET Comorbidity of
Anxiety With Eating Disorders and OCD 326
NADIA MICALI and ISOBEL HEYMAN 326-327
PER SÖDERSTEN and CECILIA BERGH 327
WALTER H. KAYE, CYNTHIA BULIK, LAURA THORNTON, and KATHERINE PLOTNICOV Dr. Kaye and
Colleagues Reply 327-329
ROBERT D. GOLDNEY Suicide Risk in Placebo-Controlled Trials of Bipolar Disorder 329
JITSCHAK G. STOROSUM, TAMAR WOHLFARTH, CHRISTIEN C. GISPEN-de WIED, DON H. LINSZEN,
BETHOLD P.R. GERSONS, BARBARA J. van ZWIETEN, and WIM van den BRINK 329
PRAVEEN F. ABRAHAM and EDWIN R. SHIRLEY New Mnemonic for Depressive Symptoms 329-330
Book Forum:
HERBERT HENDIN The American Psychiatric Publishing Textbook of Suicide Assessment and Management 331
NORMAN B. LEVY Late-Life Depression 332
ELISSA P. BENEDEK Autism Spectrum Disorders: A Research Review for Practitioners 332-333
PAUL ROAZEN Freud’s Requiem: Mourning, Memory, and the Invisible History of a Summer Walk 333-334
JAMES S. EATON, Jr. Playing Sick? Untangling the Web of Munchausen Syndrome, Munchausen by Proxy,
Malingering, and Factitious Disorder 334-335
American journal of psychiatry, n 3, vol 163, 2006
Editorials:
WILLIAM T. CARPENTER, Jr. Targeting Schizophrenia Research to Patient Outcomes 353-355
CAMERON S. CARTER Understanding the Glass Ceiling for Functional Outcome in Schizophrenia 356-358
NORA D. VOLKOW Stimulant Medications: How to Minimize Their Reinforcing Effects? 359-361
SAMUEL J. KEITH Are We Still Talking to Our Patients With Schizophrenia? 362-364
Reviews and Overviews:
Douglas Turkington, David Kingdon, and Peter J. Weiden Cognitive Behavior Therapy for Schizophrenia 365-373
Introspections:SAMUEL G. SIRIS A Tension to Detail 374-375
Treatment in Psychiatry:Tonya White, Afshan Anjum, and S. Charles Schulz The Schizophrenia Prodrome 376-380
Clinical Case Conference:
Sara E. Allison, Lisa von Wahlde, Tamra Shockley, and Glen O. Gabbard
The Development of the Self in the Era of the Internet and Role-Playing Fantasy Games 381-385
Images in Psychiatry:Arnold D. Richards and Paul W. Mosher Abraham Arden Brill, 1874–1948 386
New Research
Thomas J. Spencer, Joseph Biederman, Patrick E. Ciccone, Bertha K. Madras, Darin D. Dougherty, Ali A. Bonab,
Elijahu Livni, Dolly A. Parasrampuria, and Alan J. Fischman
PET Study Examining Pharmacokinetics, Detection and Likeability, and Dopamine Transporter Receptor Occupancy of
Short- and Long-Acting Oral Methylphenidate 387-395
Gary Remington, David Mamo, Alain Labelle, Jeffrey Reiss, Chekkera Shammi, Erik Mannaert, Steve Mann, and
Shitij Kapur
A PET Study Evaluating Dopamine D2 Receptor Occupancy for Long-Acting Injectable Risperidone 396-401